Brynna leads the business and accounting side, helping shape the welcoming and professional atmosphere the clinic is known for, while working closely alongside Adrian in overseeing the day-to-day growth and operations of the business
Many people complain of: Pain localized in the front of the knee, just below the patella Discomfort with prolonged sitting Aching when navigating stairs, especially going down Pain with squats Patellofemoral Pain Syndrome What Is It
Disclosures: Carolin Victoria Schneider: Nothing to Disclose, Rohit Loomba: Eli Lilly and Company: Consultant, Helen Huang: Nothing to Disclose, Anastasia Raptis: Nothing to Disclose, Kate Townsend Creasy: Nothing to Disclose, Jan Clusmann: Nothing to Disclose, Felix Van Haag: Nothing to Disclose, Tom Luedde: Nothing to Disclose, Sven Francque: Nothing to Disclose, Kai Markus Schneider: Nothing to Disclose 619 SPATIAL TRANSCRIPTOMICS MAPS THE METABOLIC ZONATION OF HEPATOCYTES IN MASLD I148M-PNPLA3 CARRIERS Erika Paolini 1 Miriam Longo 1 Marica Meroni 1 Anna Ludovica Fracanzani 2 Paola Dongiovanni 1 , 1 Medicine and Metabolic Diseases, Fondazione IRCCS C Granda, Ospedale Maggiore Policlinico
Benefits (Research Focus) NNMT inhibition studied as a selective small-molecule inhibitor of nicotinamide N-methyltransferase NAD+ preservation investigated for preservation of cellular NAD+ pools and downstream sirtuin pathway activity Adipose tissue research explored for lipolysis markers and fat-mass partitioning in DIO rodent models Skeletal muscle metabolism examined for endpoints related to muscle aging and sarcopenia models Metabolic signaling researched for glucose homeostasis and insulin sensitivity endpoints in metabolic disease models What Researchers Look At NNMT enzymatic activity and 1-methylnicotinamide (1-MNA) tissue concentrations Intracellular NAD+ / NADH ratio and downstream sirtuin (SIRT1/SIRT3) activation Body composition, fat mass, and lean mass partitioning in DIO rodent models Adipocyte lipolysis markers and adipose tissue inflammation profiles Glucose tolerance, insulin sensitivity, and hepatic steatosis endpoints Quick Specs Form: Lyophilized white powder Net Content: 10 mg per vial (as iodide salt) Quantity: 1 vial Appearance: White to off-white lyophilizate Reconstitution: Bacteriostatic or sterile water (added by the end researcher) Purity: 99% by HPLC Identity: MS-verified (per COA) Storage: Protect from light Identity Basics Compound: 5-Amino-1MQ (5-Amino-1-methylquinolinium iodide) Synonyms: 5-Amino-1-methylquinolinium
Area of uncertainty Clinical types of PHN need further studies to elucidate the pathogenesis and pathology of PHN types
